Cancer Control and Population Sciences
Cousin L, Braithwaite D, Anton S, Zhang Z, Lee JH, Leewenburgh C, Lyon D. A pilot study of a gratitude journaling intervention to enhance spiritual well-being and exercise self-efficacy in Black breast cancer survivors. BMC Psychiatry. 2024 Dec 18;24(1):931. doi: 10.1186/s12888-024-06362-2. PubMed PMID: 39696111; PubMed Central PMCID: PMC11656783.
Xing C, Malaty J, Malham MB, Orlando FA, Lynch A, Huo Z, Francois M, Firpi-Morell R, Fisher CL, Christou DD, Salloum RG. The potential of AB-free kava in enabling tobacco cessation via management of abstinence-related stress and insomnia: study protocol for a randomized clinical trial. BMC Complement Med Ther. 2024 Dec 21;24(1):422. doi: 10.1186/s12906-024-04722-9. PubMed PMID: 39709468; PubMed Central PMCID: PMC11662815.
Hanubal KS, Balaguru L, Rengifo D, Simko A, Galochkina Z, DeJesus R, Zhang Z, Benites C, Lee JH, Conrad D, Mendenhall W, Dziegielewski PT. Association between microvascular free-flap arterial anastomosis caliber and risk for development of osteoradionecrosis. Oral Oncol. 2024 Dec 24;161:107137. doi: 10.1016/j.oraloncology.2024.107137. Online ahead of print. PubMed PMID: 39721484.
Tang H, Zhang B, Lu Y, Donahoo WT, Singh Ospina N, Kotecha P, Lu Y, Tong J, Smith SM, Rosenberg EI, Kimmel SE, Bian J, Guo J, Chen Y. Assessing the benefit-risk profile of newer glucose-lowering drugs: A systematic review and network meta-analysis of randomized outcome trials. Diabetes Obes Metab. 2024 Dec 26. doi: 10.1111/dom.16147. Online ahead of print. PubMed PMID: 39723481.
Hargrove D, Ranjbar S, Darji M, Nam S, Dawson RJ, Katugampola S, Lin X, Brown A, Carrasco-Rojas N, Goodwin C, Howell RW, Bolch WE, Jay M, Salner A, Lu X. Tumor specific delivery and radiation-enhanced tumor penetration of mesoporous silica nanoparticles for effective radionuclide therapy of ovarian peritoneal metastasis. Int J Pharm. 2024 Dec 9;669:125071. doi: 10.1016/j.ijpharm.2024.125071. Online ahead of print. PubMed PMID: 39662854.
George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. PubMed PMID: 39626160; PubMed Central PMCID: PMC11616782.
Dunbar EK, Greer PJ, Saloman JL, Albers KM, Yadav D, Whitcomb DC; NAPS2* study group; *NAPS2 Consortium; Amann ST, Banks P, Brand R, Conwell DL, Cote G, Forsmark CE, Gardner TB, Guda NM, Lewis MD, Machicado JD, Muniraj T, Papachristou GI, Romagnuolo J, Sandhu BS, Singh VK, Sherman S, Slivka A, Wilcox CM. Genetics of Constant and Severe Pain in the NAPS2 Cohort of Recurrent Acute and Chronic Pancreatitis Patients. J Pain. 2024 Dec 12:104754. doi: 10.1016/j.jpain.2024.104754. Online ahead of print. PubMed PMID: 39674387.
Mores AL, Bonfim-Alves CG, Lopez RVM, Rodrigues-Oliveira L, Palmier NR, Mariz BALA, Migliorati CA, Kowalski LP, Santos-Silva AR, Brandao TB, Prado-Ribeiro AC. Prognostic Factors in Head and Neck Cancer: A Retrospective Cohort Study of 3052 Patients in Brazil. Oral Dis. 2024 Dec 17. doi: 10.1111/odi.15196. Online ahead of print. PubMed PMID: 39688095.
Marchiori E, Hochhegger B, Zanetti G. Pulmonary laceration. J Bras Pneumol. 2024 Dec 6;50(5):e20240270. doi: 10.36416/1806-3756/e20240270. No abstract available. PubMed PMID: 39661842; PubMed Central PMCID: PMC11601086.
Chu PW, Stewart C, Kofler C, Mahendra M, Wang Y, Chu CA, Lee C, Bolch WE, Smith-Bindman R. Representative Organ Doses from Computed Tomography (CT) Exams from a Large International Registry. Radiat Res. 2024 Dec 17. doi: 10.1667/RADE-24-00178.1. Online ahead of print. PubMed PMID: 39689286.
Carraro U, Alberty MS, Anton S, Barbieri E, Bersch I, Blaauw B, Bosco G, Forni R, Ganassi M, Gargiulo P, Gentil P, Gorgey AS, Leeuwenburgh C, Maccarone MC, Martini A, Masiero S, Mayr W, Messina G, Morra A, Narici M, Ohlendieck K, Perrin P, Pond A, Quadrelli M, Rosati R, Sestili P, Smeriglio P, Sweeney HL, Tavian D, Volk GF. Mobility Medicine: A call to unify hyper-fragmented specialties by abstracts sent to 2025Pdm3, and typescripts to Ejtm3, and Diagnostics. Eur J Transl Myol. 2024 Dec 12;34(4). doi: 10.4081/ejtm.2024.13432. PubMed PMID: 39665691.
Pea D, Assarzadegan N, Terracina K, Saulino D. Perianal Paget Disease With an Enteric Phenotype and Associated In-Situ/Dysplastic Glandular Component: Report of a Potentially Novel Entity and Review of the Literature. Int J Surg Pathol. 2024 Dec 5:10668969241297261. doi: 10.1177/10668969241297261. Online ahead of print. PubMed PMID: 39632744.
Davis A, Martin J, Cooks E, Vilaro M, Wilson-Howard D, Tang K, Raup Krieger J. From English to “Englishes”: A Process Perspective on Enhancing the Linguistic Responsiveness of Culturally Tailored Cancer Prevention Interventions. J Particip Med. 2024 Dec 19;16:e57528. doi: 10.2196/57528. PubMed PMID: 39700494.
Gellings JA, Cortina CS, Kijak J, Bradley J, Aldakkak M, Bergom C, Kong AL. Adjuvant breast radiation therapy practice patterns in the United States from 2012-2017. Surg Oncol Insight. 2024 Dec;1(4):100093. doi: 10.1016/j.soi.2024.100093. Epub 2024 Aug 25. No abstract available. PubMed PMID: 39555478; PubMed Central PMCID: PMC11566854.
Lamba J, Marchi F, Landwehr M, Schade AK, Shastri V, Ghavami M, Sckaff F, Marrero R, Nguyen N, Mansinghka V, Cao X, Slayton W, Starostik P, Ribeiro R, Rubnitz J, Klco J, Gamis A, Triche T Jr, Ries R, Kolb EA, Aplenc R, Alonzo T, Pounds S, Meshinchi S, Cogle C, Elsayed A. Long-read epigenomic diagnosis and prognosis of Acute Myeloid Leukemia. Res Sq [Preprint]. 2024 Dec 12:rs.3.rs-5450972. doi: 10.21203/rs.3.rs-5450972/v1. PubMed PMID: 39711573; PubMed Central PMCID: PMC11661290.
Cancer Targeting and Therapeutics
Gupta S, Rau RE, Kairalla JA, Rabin KR, Wang C, Angiolillo AL, Alexander S, Carroll AJ, Conway S, Gore L, Kirsch I, Kubaney HR, Li AM, McNeer JL, Militano O, Miller TP, Moyer Y, O’Brien MM, Okada M, Reshmi SC, Shago M, Wagner E, Winick N, Wood BL, Haworth-Wright T, Zaman F, Zugmaier G, Zupanec S, Devidas M, Hunger SP, Teachey DT, Raetz EA, Loh ML. Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children. N Engl J Med. 2024 Dec 7. doi: 10.1056/NEJMoa2411680. Online ahead of print. PubMed PMID: 39651791.
Lamba J, Marchi F, Landwehr M, Schade AK, Shastri V, Ghavami M, Sckaff F, Marrero R, Nguyen N, Mansinghka V, Cao X, Slayton W, Starostik P, Ribeiro R, Rubnitz J, Klco J, Gamis A, Triche T Jr, Ries R, Kolb EA, Aplenc R, Alonzo T, Pounds S, Meshinchi S, Cogle C, Elsayed A. Long-read epigenomic diagnosis and prognosis of Acute Myeloid Leukemia. Res Sq [Preprint]. 2024 Dec 12:rs.3.rs-5450972. doi: 10.21203/rs.3.rs-5450972/v1. PubMed PMID: 39711573; PubMed Central PMCID: PMC11661290.
Nguyen NH, Rafiee R, Parcha PK, Tagmount A, Rubnitz J, Ribeiro RC, Cao X, Pounds SB, Vulpe CD, Lamba JK. Genome-wide CRISPR screen identifies AraC-Dauno-Eto (ADE) response modulators that predicts outcome in pediatric AML. Blood Adv. 2024 Dec 23:bloodadvances.2024014157. doi: 10.1182/bloodadvances.2024014157. Online ahead of print. PubMed PMID: 39715471.
George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. PubMed PMID: 39626160; PubMed Central PMCID: PMC11616782.
Luesch H, Ellis EK, Chen QY, Ratnayake R. Progress in the discovery and development of anticancer agents from marine cyanobacteria. Nat Prod Rep. 2024 Dec 2. doi: 10.1039/d4np00019f. Online ahead of print. PubMed PMID: 39620500; PubMed Central PMCID: PMC11610234.
McKean J, Parrish A, Kahramangil Baytar D, Paniccia A, Hughes S, Nassour I. Oncologic Efficacy of Robotic Compared to Open Total Pancreatectomy for Pancreatic Cancer. J Surg Res. 2024 Dec 3;305:19-25. doi: 10.1016/j.jss.2024.10.043. Online ahead of print. PubMed PMID: 39631324.
Hanubal KS, Balaguru L, Rengifo D, Simko A, Galochkina Z, DeJesus R, Zhang Z, Benites C, Lee JH, Conrad D, Mendenhall W, Dziegielewski PT. Association between microvascular free-flap arterial anastomosis caliber and risk for development of osteoradionecrosis. Oral Oncol. 2024 Dec 24;161:107137. doi: 10.1016/j.oraloncology.2024.107137. Online ahead of print. PubMed PMID: 39721484.
Lee D, Kozurek EC, Abdullah M, Wong EJ, Li R, Liu ZS, Nguyen HD, Dickerson EB, Kim JH. PIK3CA mutation fortifies molecular determinants for immune signaling in vascular cancers. Cancer Gene Ther. 2024 Dec 21. doi: 10.1038/s41417-024-00867-4. Online ahead of print. PubMed PMID: 39709507.
Wu Z, Smith AR, Qian Z, Zheng G. Patent landscape of small molecule inhibitors of METTL3 (2020-present). Expert Opin Ther Pat. 2024 Dec 26:1-16. doi: 10.1080/13543776.2024.2447056. Online ahead of print. PubMed PMID: 39721070.
Agrahari V, Choonara YE, Mosharraf M, Patel SK, Zhang F. The Role of Artificial Intelligence and Machine Learning in Accelerating the Discovery and Development of Nanomedicine. Pharm Res. 2024 Dec;41(12):2289-2297. doi: 10.1007/s11095-024-03798-9. Epub 2024 Dec 2. PubMed PMID: 39623144.
Xu H, Zhang S, Song K, Yang H, Yin J, Huang Y. Droplet-based 3D bioprinting for drug delivery and screening. Adv Drug Deliv Rev. 2024 Dec 10;217:115486. doi: 10.1016/j.addr.2024.115486. Online ahead of print. PubMed PMID: 39667692.
Zhou X, Jaiswal M, Shi J, Guo J, Kundu S, Guo Z, Zeng Y. Efficient Enzymatic Glycan Engineering of Extracellular Vesicles Using Nanomaterial-Interfaced Microfluidics. ACS Appl Mater Interfaces. 2024 Dec 19. doi: 10.1021/acsami.4c20294. Online ahead of print. PubMed PMID: 39698856.
Dietz MS, Al-Ibraheemi A, Davis JL, Hawkins CM, Craig BT, Dasgupta R, Geller DS, Shulman DS, Cohen-Gogo S, Gupta A, Whiteway SL, Slotkin EK, Heske CM, Ahmed SK, Indelicato DJ, Albert CM, Montgomery N, Sandberg JK, Grier HE, Krailo M, Isakoff MS, Rubin E, Lawlor ER, DuBois SG, Mascarenhas L, Grohar PJ, Binitie O, Reed D, Janeway K, Roberts RD, Bailey KM. Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children’s Oncology Group Bone Tumor Committee Consensus Statement. J Natl Compr Canc Netw. 2024 Dec 27:1-7. doi: 10.6004/jnccn.2024.7063. Online ahead of print. PubMed PMID: 39729709.
Kahramangil D, Zarrinpar A, Sahin I. Immune checkpoint inhibitors in the post-transplant landscape of hepatocellular carcinoma: A systematic literature review. Liver Transpl. 2024 Dec 16. doi: 10.1097/LVT.0000000000000550. Online ahead of print. PubMed PMID: 39670878.
Yassin O, Praveen B, Darawshi O, LaFramboise T, Shmuel M, Pattanayak SP, Law BK, Hatzoglou M, Tirosh B. Opposing regulation of endoplasmic reticulum retention under stress by ERp44 and PDIA6. Biochem J. 2024 Dec 18;481(24):1921-1935. doi: 10.1042/BCJ20240444. PubMed PMID: 39621446.
Pea D, Assarzadegan N, Terracina K, Saulino D. Perianal Paget Disease With an Enteric Phenotype and Associated In-Situ/Dysplastic Glandular Component: Report of a Potentially Novel Entity and Review of the Literature. Int J Surg Pathol. 2024 Dec 5:10668969241297261. doi: 10.1177/10668969241297261. Online ahead of print. PubMed PMID: 39632744.
Willette C, Bini G, Traverson M, Liptak JM, Hollenbeck D, Maxwell EA, de Mello Souza CH, Wustefeld-Janssens B, Selmic L. Retrospective evaluation of the influence of phenoxybenzamine pretreatment on intraoperative cardiovascular variables in dogs with pheochromocytoma. Can Vet J. 2024 Dec;65(12):1293-1301. PubMed PMID: 39649740; PubMed Central PMCID: PMC11618959.
Immuno-Oncology and Microbiome
Katz J. Clarification Regarding the Association of Cannabis Use and Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2024 Dec 5. doi: 10.1001/jamaoto.2024.4168. Online ahead of print. No abstract available. PubMed PMID: 39636627.
George TJ, Lee JH, DeRemer DL, Hosein PJ, Staal S, Markham MJ, Jones D, Daily KC, Chatzkel JA, Ramnaraign BH, Close JL, Ezenwajiaku N, Murphy MC, Allegra CJ, Rogers S, Zhang Z, Li D, Srinivasan G, Shaheen M, Hromas R. Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms. JCO Precis Oncol. 2024 Dec;8:e2400406. doi: 10.1200/PO-24-00406. Epub 2024 Dec 3. PubMed PMID: 39626160; PubMed Central PMCID: PMC11616782.
Jang T, Burnside RD, Chaffin J, Seifert R, Hiemenz JW. Severe aplastic anemia with acquired X chromosome clonality as a sole abnormality. Ann Hematol. 2024 Dec 31. doi: 10.1007/s00277-024-06166-0. Online ahead of print. PubMed PMID: 39738592.
He Z, Yu J, Gong J, Wu J, Zong X, Luo Z, He X, Cheng WM, Liu Y, Liu C, Zhang Q, Dai L, Ding T, Gao B, Gharaibeh RZ, Huang J, Jobin C, Lan P. Campylobacter jejuni-derived cytolethal distending toxin promotes colorectal cancer metastasis. Cell Host Microbe. 2024 Dec 11;32(12):2080-2091.e6. doi: 10.1016/j.chom.2024.11.006. Epub 2024 Dec 2. PubMed PMID: 39626677.
Wi T, Choi Y, Kim J, Choi YS, Pipkin ME, Choi J. Efficient gene deletion of Integrin alpha 4 in primary mouse CD4 T cells using CRISPR RNA pair-mediated fragmentation. Front Immunol. 2024 Dec 10;15:1445341. doi: 10.3389/fimmu.2024.1445341. eCollection 2024. PubMed PMID: 39720725; PubMed Central PMCID: PMC11666438.
Wu Z, Smith AR, Qian Z, Zheng G. Patent landscape of small molecule inhibitors of METTL3 (2020-present). Expert Opin Ther Pat. 2024 Dec 26:1-16. doi: 10.1080/13543776.2024.2447056. Online ahead of print. PubMed PMID: 39721070.
McKean J, Parrish A, Kahramangil Baytar D, Paniccia A, Hughes S, Nassour I. Oncologic Efficacy of Robotic Compared to Open Total Pancreatectomy for Pancreatic Cancer. J Surg Res. 2024 Dec 3;305:19-25. doi: 10.1016/j.jss.2024.10.043. Online ahead of print. PubMed PMID: 39631324.
Mechanisms of Oncogenesis
Wu Q, Yu C, Yu F, Guo Y, Sheng Y, Li L, Li Y, Zhang Y, Hu C, Wang J, He TC, Huang Y, Ni H, Huo Z, Wu W, Wang GG, Lyu J, Qian Z. Evi1 governs Kdm6b-mediated histone demethylation to regulate the Laptm4b-driven mTOR pathway in hematopoietic progenitor cells. J Clin Invest. 2024 Dec 16;134(24):e173403. doi: 10.1172/JCI173403. PubMed PMID: 39680456; PubMed Central PMCID: PMC11645144.
Wang Y, Xiong C, Yu W, Zhou M, Shugg T, Hsu FC, Eadon MT, Su J, Song Q. PCCA variant rs16957301 is a novel AKI risk genotype-specific for patients who receive ICI treatment: Real-world evidence from all of us cohort. Eur J Cancer. 2024 Dec;213:115114. doi: 10.1016/j.ejca.2024.115114. Epub 2024 Nov 9. PubMed PMID: 39536432.
Berardi A, Kaestner CL, Ghitti M, Quilici G, Cocomazzi P, Li J, Ballabio F, Zucchelli C, Knapp S, Licht JD, Musco G. The C-terminal PHDVC5HCH tandem domain of NSD2 is a combinatorial reader of unmodified H3K4 and tri-methylated H3K27 that regulates transcription of cell adhesion genes in multiple myeloma. Nucleic Acids Res. 2024 Dec 5:gkae1121. doi: 10.1093/nar/gkae1121. Online ahead of print. PubMed PMID: 39656918.
Augustin B, Wu D, Black LP, Bertrand A, Sulaiman D, Hopson C, Jacob V, Shavit JA, Hofmaenner DA, Labilloy G, Smith L, Cagmat E, Graim K, Datta S, Reddy ST, Guirgis FW. Multiomic molecular patterns of lipid dysregulation in a subphenotype of sepsis with higher shock incidence and mortality. Crit Care. 2024 Dec 24;28(1):431. doi: 10.1186/s13054-024-05216-3. PubMed PMID: 39716214; PubMed Central PMCID: PMC11667828.
Brown ME, Thirawatananond P, Peters LD, Kern EJ, Vijay S, Sachs LK, Posgai AL, Brusko MA, Shapiro MR, Mathews CE, Bacher R, Brusko TM. Inhibition of CD226 co-stimulation suppresses diabetes development in the NOD mouse by augmenting regulatory T cells and diminishing effector T cell function. Diabetologia. 2024 Dec 5. doi: 10.1007/s00125-024-06329-8. Online ahead of print. PubMed PMID: 39636437.
Wu Z, Smith AR, Qian Z, Zheng G. Patent landscape of small molecule inhibitors of METTL3 (2020-present). Expert Opin Ther Pat. 2024 Dec 26:1-16. doi: 10.1080/13543776.2024.2447056. Online ahead of print. PubMed PMID: 39721070.
Torma G, Dormo A, Fulop A, Tombacz D, Mizik M, Pretory AM, Lee SC, Toth Z, Boldogkoi Z. Long-read Transcriptomics of Caviid Gammaherpesvirus 1: Compiling a Comprehensive RNA Atlas. bioRxiv [Preprint]. 2024 Dec 13:2024.12.11.627975. doi: 10.1101/2024.12.11.627975. PubMed PMID: 39713410; PubMed Central PMCID: PMC11661164.